Antiviral Drugs Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Antiviral Drugs Market by drug type (drugs and generic drugs), therapeutics(HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes therapeutics, influenza therapeutics and others) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Antiviral Drugs Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Antiviral Drugs Market are Roche Holding AG, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott Healthcare, Med Immune/AstraZeneca, Schering-Plough, Johnson & Johnson, Merck & Co, Gilead Sciences, Dr Reddy, and Cipla. According to the report the Global Antiviral Drugs Market is projected to grow at a CAGR between 4.0 % to 4.5 % in terms of value over the period of 2017-2023.
Increasing Incidences of Epidemics in Viral Infections Such As Influenza, Respiratory Syncytial Virus and Others Anticipated To Provide Massive Growth Opportunities for this Market
Global antiviral drugs market has grown moderately over the past few years, but during the forecast period this market likely to have healthy gains. As of 2023, as per the WHO 35.3 Mn people were infected with HIV globally, hence increased in viral infection incidences considered as one of the strong driving force in this market. Due to which robust R&D activities, advanced treatments and formulations such as vaccines, combination therapy, and others introduced in the market. Moreover, Strong research and development activities have led to introduction of new drugs with better efficacy and less side effects thereby contributing significantly in the global growth. On the other hand, High risk of failure, higher cost associated with research and development activities, and stringent government regulations are the major growth barriers inhibiting global growth of this market.Increasing incidences of epidemics in viral infections such as influenza, respiratory syncytial virus and others anticipated to provide massive growth opportunities for this market over the forecast period. Whereas, High cost associated with development of new drugs and usage of natural products will pose as major challenge in front of this market.
The report segments the global antiviral drugs market by drug type, by therapeutics, by end user, and by region. The market size of each segment has been provided in terms of value (USD) and volume (tons). Market segmentation based on type includes branded drugs and generic drugs. On the basis of therapeutics global market has been divided into HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes therapeutics, influenza therapeutics and others (Pneumonia). Market segmentation based on end user includes hospitals, clinics, and ambulatory surgical center
Click the Below Full Report:-